Cleary Chris 4

4 · Orchestra BioMed Holdings, Inc. · Filed Jun 25, 2026

AI-generated summary of this filing

Updated Jun 25, 2026

Orchestra BioMed (OBIO) Director Chris Cleary Receives Option Grant

What Happened

Chris Cleary, a director of Orchestra BioMed (OBIO), was granted a derivative award covering 42,553 shares on 2026-06-23 (reported at $0.00). The filing also shows 3,510 shares were withheld on 2026-06-24 to satisfy tax withholding related to vested RSUs (reported disposition at $0.00). No cash proceeds were reported for the withheld shares.

Key Details

Transaction dates and reported prices:
- 2026-06-23: Grant/award (derivative) — 42,553 shares @ $0.00 (Acquired)
- 2026-06-24: Tax withholding for RSU vesting — 3,510 shares @ $0.00 (Disposed)
Reported monetary values on the Form 4 are $0 for both transactions (typical for grants/withholdings as reported).
Shares owned following the transactions: not specified in the filing.
Footnotes:
- F1: The 3,510-share disposition represents shares withheld by the issuer to satisfy tax withholding for vested RSUs; no market sale occurred.
- F2: The 42,553-share grant consists of stock options that will vest on the one‑year anniversary of the 6/23/2026 grant, subject to Cleary's continued service.
Filing timeliness: Form filed 2026-06-25 for transactions on 6/23–6/24/2026 — filed within the typical two-business-day window (i.e., appears timely).

Context

The 3,510-share action was a tax withholding event (not a sale), so it doesn't indicate immediate market-selling by the insider.
The 42,553-share entry is a derivative grant (options) that vest in one year if service conditions are met; these are not immediate share purchases and do not provide immediate liquidity.

Form 4

Period: 2026-06-23

Director

Transactions

Tax Payment
Common Stock, par value $0.0001 per share
[F1]
2026-06-24−3,510→ 33,391 total
Award
Stock Option (Right to Buy)
[F2]
2026-06-23+42,553→ 42,553 total
Exercise: $4.04Exp: 2036-06-23→ Common Stock (42,553 underlying)

Footnotes (2)

[F1]Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.
[F2]The stock options will vest on the one year anniversary of June 23rd, 2026 (the "Grant Date"), subject to the Reporting Person's continuous service through such date.

Signature

/s/ Andrew Taylor, Attorney-in-Fact|2026-06-25

1 file